06/23/2025
6:42 PM | Axsome Therapeutics (Issuer)
Murdock Hunter R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
8:16 PM | Axsome Therapeutics (Issuer)
Murdock Hunter R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
3:42 PM | Axsome Therapeutics (Subject)
Murdock Hunter R. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/16/2025
3:17 PM | Axsome Therapeutics (Subject)
Murdock Hunter R. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2025
6:00 PM | Axsome Therapeutics (Issuer)
Mahony Susan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2025
6:00 PM | Axsome Therapeutics (Issuer)
Jacobson Mark L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2025
6:00 PM | Axsome Therapeutics (Issuer)
Saad Mark E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2025
6:00 PM | Axsome Therapeutics (Issuer)
JEFFS ROGER (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2025
6:00 PM | Axsome Therapeutics (Issuer)
Coleman Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2025
6:24 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/09/2025
6:05 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for AXSM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Axsome Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
05/29/2025
6:00 PM | Axsome Therapeutics (Issuer)
Coleman Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2025
8:52 PM | Axsome Therapeutics (Issuer)
Jacobson Mark L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/27/2025
3:45 PM | Axsome Therapeutics (Subject)
Coleman Mark (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/27/2025
3:46 PM | Axsome Therapeutics (Subject)
Jacobson Mark L. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/27/2025
6:05 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2025
8:46 PM | Axsome Therapeutics (Issuer)
Coleman Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2025
4:54 PM | Axsome Therapeutics (Subject)
Coleman Mark (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/15/2025
7:09 AM | Axsome Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SCHEDULE 13G/A | |
05/13/2025
6:06 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/05/2025
3:47 PM | Axsome Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/05/2025
6:33 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2025
3:31 PM | Axsome Therapeutics (Filer)
| Form DEF 14A | |
04/25/2025
3:32 PM | Axsome Therapeutics (Filer)
| Form DEFA14A | |
04/25/2025
3:33 PM | Axsome Therapeutics (Filer)
| Form ARS | |
04/01/2025
6:06 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2025
6:06 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2025
6:05 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/03/2025
6:06 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/25/2025
6:56 PM | Axsome Therapeutics (Issuer)
Murdock Hunter R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
6:57 PM | Axsome Therapeutics (Issuer)
Maizel Ari (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
6:59 PM | Axsome Therapeutics (Issuer)
Saad Mark E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
7:00 PM | Axsome Therapeutics (Issuer)
JEFFS ROGER (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
7:02 PM | Axsome Therapeutics (Issuer)
Mahony Susan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
6:51 PM | Axsome Therapeutics (Issuer)
TABUTEAU HERRIOT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
6:53 PM | Axsome Therapeutics (Issuer)
Jacobson Mark L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
6:54 PM | Axsome Therapeutics (Issuer)
Pizzie Nick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
6:06 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
8:20 PM | Axsome Therapeutics (Issuer)
Pizzie Nick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
8:00 AM | Axsome Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SCHEDULE 13G/A | |
02/10/2025
6:06 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Ex-Hedge Fund Manager Uncovers $100 Trillion Land Shift (Ad) Trump's Radical New Plan Could Enrich Thousands
This isn't a campaign stunt. It's a $100 trillion move to unlock federal lands, oil reserves, and buried minerals... all for profit. Trump's team is already executing the orders... and Wall Street legend Whitney Tilson is stepping forward to show you how to position before the deadline. Click here to see the full story. |
01/13/2025
6:05 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/30/2024
6:56 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/26/2024
6:05 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
8:43 AM | Axsome Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/24/2024
5:23 PM | Axsome Therapeutics (Issuer)
Maizel Ari (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/01/2024
4:24 PM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2024
6:00 PM | Axsome Therapeutics (Issuer)
Saad Mark E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
3:32 PM | Axsome Therapeutics (Subject)
Saad Mark E (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/04/2024
6:05 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/21/2024
6:05 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
6:27 PM | Axsome Therapeutics (Issuer)
Jacobson Mark L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2024
6:05 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
